Paloma Partners’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-51,600
Closed -$509K 1252
2022
Q3
$509K Hold
51,600
0.02% 475
2022
Q2
$505K Hold
51,600
0.02% 616
2022
Q1
$505K Hold
51,600
0.01% 747
2021
Q4
$506K Buy
+51,600
New +$504K 0.01% 1094

Paloma Partners's SHAC Position: Q4 2022 in Review

Paloma Partners sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 51,600 shares — an estimated $509K sold.

Paloma Partners first reported a position in SHAC in Q4 2021 and held it in 4 quarters. The position peaked at $509K in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

  • Paloma Partners reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Paloma Partners sold 51,600 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $509K.
  • Paloma Partners first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • Paloma Partners's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $509K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Paloma Partners's 13F filing for Q4 2022, filed 14 Feb 2023.